Long-Term Treatment of Growth Hormone Insensitivity Syndrome with IGF-I
Michael B. Ranke(University Children's Hospital Tübingen), Patrick Wilton, M O Savage(St Bartholomew's Hospital), Pierre Chatelain(Hôpital Edouard Herriot), Michael A. Preece, R G Rosenfeld(Laboratório Interinstitucional de e-Astronomia)
Cited by 117
Related Papers
Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition
|Journal of Biological Chemistry|1993|477
Recommendations for the Diagnosis and Management of Turner Syndrome<sup>1</sup>
|The Journal of Clinical Endocrinology & Metabolism|2001|354
Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective
|Hormone Research in Paediatrics|2019|345
Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease
|Journal of Endocrinology|1994|271
Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
|The Journal of Clinical Endocrinology & Metabolism|1993|203